Home
    Scientific Program
    Registration
    Accommodation
    Contact
     Home
     Welcome Note
     Committees
     Timetable
     Scientific Program
     Faculty
     Poster Presentation Schedule
         Group A
         Group B
         Poster Presentation Guidelines
     Registration
     Accommodation
         Pullman Montparnasse
     Sponsorship & Exhibition
     Sponsors
     CME
     General Information
         Italian Agent
         Before you travel...
         2012 Congress feedback lottery
     Invitation Letter
     Partners
     About Paris
     Past Congresses
     CURy 2010 Webcasting
The 4th World Congress on
Controversies in Urology (CURy)
Paris, France, January 27-30, 2011
  Group B Print
KIDNEY CANCER
Poster Board 1
PLASMA HOMOCYSTEINE IN ESRD PATIENTS
M. Babaei1, S. Gerayeshnejad1, N. Dashti1, K. Abdi1, F. Nazari2                    
1Tehran University of Medical Sciences, Tehran-Iran; 2Zanjan University of Medical Sciences,Tehran-Iran

Poster Board 2
PROGRESSION OF INDETERMINATE PULMONARY NODULES FOUND ON STAGING CT IN RENAL CELL CARCINOMA
D.J. Black, R. Zakri, D. Magrill, V. Kalsi, N.J. Barber                     
Frimley Park Hospital, Frimley, UK

Poster Board 3
BONE-MARKER LEVELS AND POTENTIAL CORRELATION WITH OUTCOMES IN PATIENTS WITH RENAL CANCER AND BONE METASTASIS: PRELIMINARY RESULTS OF TUGAMO TRIAL
E. Esteban1, J.L. lvarez-Ossorio2, M.A. Climent3, H. Ascaso4,
A. Gonzalez del Alba5, B. Mellado6, F. Vazquez7, V. Calderero8, I. Chirivella9,
J.M. Fernandez1, B. Gonzalez 
1Hospital Central de Asturias, Oviedo; 2Hospital Puerta del Mar, Cadiz; 3Instituto Valenciano de Oncologia, Valencia; 4Hospital Universitari Joan XXII, Tarragona; 5Hospital Son Dureta, Mallorca; 6Hospital Clinic i Provincial de Barcelona; 7Hospital Universitario Virgen de las Nieves, Granada; 8Hospital Universitario Miguel Servet, Zaragoza; 9Hospital Clinico de Valencia, Valencia, Spain

Poster Board 4
HIGH INCIDENCE OF RENAL CELL CARCINOMA IN PATIENTS WITH HISTORY OF DIABETES
S.L Habib1
,2,  T.J Prihoda3, M. Luna2, S.A. Werner3                        
1Geriatric Research, Education, and, Clinical Center, South Texas Veterans Healthcare System, San Antonio, Texas
2Department of Medicine & 3Department of Pathology, University of Texas Health Science Center and San Antonio, Texas, USA

Poster Board 5
RADIOFREQUENCY ABLATION IN TREATMENT OF RENAL TUMOURS
M. Jasinski1, J. Siekiera1, K. Kamecki1, A. Krasnicki1, W. Mikolajczak1, A. Petrus1,
A. Wronczewski1, W. Jozwicki2, T. Drewa1,3        
1Department of Oncological Urology, Oncology Centre Bydgoszcz, Poland
2Department of Pathology, Oncology Centre Bydgoszcz, Poland
3Department of Tissue Engineering, Nicolaus Copernicus University, Bydgoszcz, Poland

Poster Board 6
LAPAROSCOPIC RADICAL NEPHRECTOMY FOR TUMORS <10 cm
N.G Kalogeras2
, S. Giannakopoulos1, T. Pantazis1, S. Giannopoulos1, G. Tsakaldimis1,
E. Patris1, S. Touloupidis1              
1Department of Urology, Democritus University of Thrace, Alexandroupolis, Greece & 2General Hospital of Karditsa, Department of Urology, Karditsa, Greece

Poster Board 7
EXPRESSION OF CLAUDIN-1 AND 7 IN CLEAR CELL RENAL CELL CARCINOMA AND ITS CLINICAL SIGNIFICANCE
C.I. Kim
, C.H. Park, H.S. Chang, B.H. Kim                         
Department of Urology, Keimyung University School of Medicine, Daegu, Korea

Poster Board 8
CAN WE CORRELATE TREAT THE KIDNEY CANCER WITH INTRA-OPERATIVE HEMOSTASIS? ESTABLISHING MODEL FOR SPECIFIC HEMOSTASIS BIOMATERIALS COVERED WITH CYTOSTATICS ON A MOUSE C57B1/J KIDNEY MELANOMA
M.S. Nowacki1
, A. Jundzill1,2, T.A. Drewa1,3                           
1Tissue Engineering Department, chair of Medical Biology, Collegium Medicum, Nicolaus Copernicus University in Bydgoszcz, Poland
2Department of General and Vascular Surgery, Collegium Medicum, Nicolaus Copernicus University in Bydgoszcz, Poland
3Division of Clinical Urology & Oncology - Oncology Centre - prof. Franciszek Łukaszczyk memorial hospital in Bydgoszcz, Poland

Poster Board 9
COMPARISON OF OPEN VERSUS ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY
J.J. Oh
, S.S. Byun, S.E. Lee, S.K. Hong, S.J. Jeong
Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea

Poster Board 10
EARLY OUTCOMES OF LESS NEPHRECTOMY EXPERIENCE
R.E. Sanchez-Salas1, V. Flamand1, J. Chan1, M. Galiano1, F. Rozet1, E. Barret1,
X. Cathelineau1              
1Institut Montsouris, Paris, France

Poster Board 11
MRI-GUIDED RADIOTHERAPY FOR ABLATION OF RENAL CELL CARCINOMA IN A SINGLE NON-INVASIVE TREATMENT
M.K. Stam1, B.W. Raaymakers1, E.M. Kerkhof1, B.A. Zonnenberg2, J.J.W. Lagendijk1,
M. Van Vulpen1                 
1Department of Radiotherapy & 2Department of Internal Medicine, UMC Utrecht, Utrecht, The Netherlands

Poster Board 12
LESS: INITIAL EXPERIENCE IN A UK DISTRICT GENERAL HOSPITAL.
S.P. Wozniak1
, K. Sairam1,2, R. Isworth1                           
1Queen Elizabeth Hospital, Woolwich, London, UK& 2Global Hospitals & Health City Perumbakkam Chennai, India

MEN'S HEALTH & ED
Poster Board 13
EFFICACY AND SAFETY OF VARDENAFIL ORODISPERSIBLE TABLET FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN ELDERLY MEN AND THOSE WITH UNDERLYING CONDITIONS
G.A. Dijkman1, H. Sperling2, M. Gittelman3, C. Norenberg4, E. Ulbrich5, S. Ewald4
1Andros Mannenkliniek, Maastricht, The Netherlands
2Kliniken Maria Hilf GmbH, Mönchengladbach, Germany
3Department of Urology, South Florida Medical Research, Aventura, FL, USA
4Bayer HealthCare AG, Wuppertal, Germany
5Bayer Vital GmbH, Leverkusen, Germany

Poster Board 14
INTRAMUSCULAR TESTOSTERONE UNDECANOATE FOR SUBSTITUTION IN MALE HYPOGONADISM: THE EXPERIENCE OF 13.5 YEARS
F.A Saad1,2, M. Zitzmann3                               
1Bayer Schering Pharma, Scientific Affairs Men's Healthcare, Berlin, Germany
2Gulf Medical University School of Medicine, Ajman, UAE
3Centre of Reproductive Medicine and Andrology of the University, Muenster, Germany

Poster Board 15
SAFETY STUDY OF LONG-ACTING PARENTERAL TESTOSTERONE UNDECANOATE OVER 42 MONTHS
F.A. Saad1,2, A. Haider3, A. Yassin2,4, L. Gooren5                        
1Bayer Schering Pharma, Scientific Affairs Men's Healthcare, Berlin, Germany
2Gulf Medical University School of Medicine, Ajman, UAE
3Private Urology Praxis, Bremerhaven, Germany
4Institute for Andrology and Urology, Norderstedt, Germany
5Department of Endocrinology, VUmc, Amsterdam, The Netherlands

Poster Board 16
PROSTATE HEALTH & SAFETY PARAMETERS: HYPOGONADAL PATIENTS ON TRT ARE NOT AT HIGHER RISK THAN EUGONADAL SUBJECTS OF AGE-MATCHED CONTROL GROUP -PROSPECTIVE COMPARATIVE 6-YEARS FU ANALYSIS
A. A. Yassin1,2,3, A. D.-J. Yassin4, F.A. Saad5,6                           
1Institute of Urology & Andrology, Segeberger Kliniken, Norderstedt-Hamburg/Germany
2Dresden International University, Program of Preventive Medicine, Dresden/Germany
3Gulf Medical University School of Medicine, Ajman/UAE
4Asklepios Klinik Barmbek, Dept. of Urology, Hamburg/Germany
5Bayer Schering Pharma AG, Berlin/Germany
6Gulf Medical University School of Medicine, Research Dept., Ajman/UAE

PROSTATE CANCER
Poster Board 17
THINK OUTSIDE THE BOX: EXTRAPERITONEAL ROBOTIC ASSISTED RADICAL PROSTATECTOMY (RALP), CHALLENGES, SOLUTIONS AND BENEFITS
H.M. Alnajjar, S. Mukhtar, R. Issa, K. Ghani, M.J. Perry, C.J. Anderson                  
St George's Healthcare NHS Trust, London, UK
 
Poster Board 18
GENE EXPRESSION OF BCL-2 FAMILY AND PROTEINS INVOLVED IN THE MITOCHONDRIAL TRANSPORT SYSTEMS (V, DAC AND TOMM) AS POSSIBLE MARKER FOR PROSTATE CANCER
A. Asmarinah1
, R. Kodariah2, B. Tanurahardja2, C. Arif Mochtar3, Y. Budiningsih4, A. Paradowszka5, K. Steger5,
W. Weidner5, E. Hinsch5        
1Department of Medical Biology, Faculty of Medicine, Universitas Indonesia; 2Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia; 3Department of Urology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital; 4Department of Forensic Medicine and Medicolegal, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
5Department of Urology, Pediatric Urology and Andrology, Justus-Liebig University of Giessen, Germany

Poster Board 19
ACCESS TO INFORMATION AND EXPECTATIONS OF TREATMENT DECISIONS AMONG EUROPEAN PROSTATE CANCER PATIENTS
E.S. Baskin-Bey1, B. Tombal2, C. Schulman3
1Astellas Pharma Europe, Department of Urology, Staines, United Kingdom; 2Cliniques Universitaires Saint-Luc, Avenue Hippocrate, Brussels, Belgium; 3Clinic Edith Cavell and University of Brussels, Brussels, Belgium

Poster Board 20
TREATMENT PATTERNS AND CHARACTERISTICS OF EUROPEAN CASTRATION RESISTANT PROSTATE CANCER (CRPC) PTS
E. Baskin-Bey1, M. Watson1, A. Worsfold2, A. Rider2 B. Tombal3, C. Sternberg4
1Astellas Pharma Europe, Staines, Middlesex, UK; 2Adelphi Real World, Macclesfield, Cheshire, UK; 3Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium; 4San Camillo and Forlanini Hospitals, Rome, Italy

Poster Board 21
CLINICIAN’S PERCEPTION OF THE RELATION WITH PROSTATE CANCER PATIENTS IN MULTIDISCIPLINARY VERSUS ONE ON ONE SETTING
L. Bellardita
, S. Donegani, D. Villani, R. Valdagni                        
Prostate Program, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Poster Board 22
THE ROLE OF MENTAL HEALTH STATUS ON QUALITY OF LIFE IN PROSTATE CANCER PATIENTS WHO CHOOSE ACTIVE SURVEILLANCE
L. Bellardita1
, D. Villani1, S. Donegani1, R. Salvioni3, S. Stagni3, N. Nicolai3, N. Bedini2,  B. Avuzzi2, C. Marenghi1, T. Magnani1, T. Rancati1, R. Valdagni1
1Programma Prostata &2 Radiation Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori & 3Urology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Poster Board 23
PROSTATE-SPECIFIC ANTIGEN (PSA) PROGRESSION: DEGARELIX VERSUS LEUPROLIDE IN PROSTATE CANCER (PCA)
L. Boccon-Gibod1
, B. Tombal2, K. Miller3, F. Schrader4, J.-K. Jensen5, B.-E. Persson6                 
1Groupe Hospitalier Bichat-Claude Bernard, Paris, France
2Cliniques Universitaires Saint Luc/Universitי Catholique de Louvain, Brussels, Belgium
3Charitי Universitהtsmedizin, Berlin, Germany
4Erasmus University Medical Center, Rotterdam, The Netherlands
5Ferring Pharmaceuticals A/S, Copenhagen, Denmark
6Ferring Pharmaceuticals, Saint-Prex, Switzerland

Poster Board 24
VALUE OF TOTAL TESTOSTERONE AND TOTAL TESTOSTERONE/TOTAL PSA RATIO IN THE DIFFERENTIATION OF PROSTATIC PATHOLOGIES
F.J.S. Botelho1
,2, F. Pina1, L. Figueiredo1, F. Cruz1, N. Lunet2                    
1Department of Urology, S. João Hospital, Porto, Portugal
2Department of Hygiene and Epidemiology, University of Porto Medical School, Porto, Portugal

Poster Board 25
COMBINATION THERAPY OF ETHINYLESTRADIOL AND ESTRAMUSTINE PHOSPHATO REINTRODUCES OBJECTIVE CLINICAL RESPONSES IN PATIENTS WITH ANDROGEN ABLATION REFRACTORY PROSTATE CANCER (EARLY ESXPERIENCE)
F. Di Silverio
, A. Sciarra, G.M. Busetto, S. Salsiccia, V. Gentile                    
Department of Urology, Sapienza Rome University, Rome, Italy
 
Poster Board 26
PROSTATE CANCER: A NEWLY DISCOVERED ROUTE FOR TESTOSTERONE TO REACH THE PROSTATE DIRECTLY FROM THE TESTES. NOVEL PATHOPHYSIOLOGICAL MECHANISM
Y. Gat1
,2, M. Goren2, S. Joshua2, M. Heiblum1, E. Rosenbaum3                    
1Weizmann Institute of Science Sub Micron Research; 2Mayanei Hayeshua Hospital, Andrology & Radiology,
3Rabin Medical Center, Department of Oncolgy, Davidoff Research Center, Rehovot, Israel

Poster Board 27

URINARY CONTINENCE AND ERECTILE FUNCTION IN PATIENTS AFTER OPEN RADICAL RETROPUBIC NERVE-SPARING PROSTATECTOMY: TWO SIDES OF ONE ITEM?
E.N. Golubtsova
, E.I. Veliev, S.V. Kotov                            
Russian Medical Academy of Postgraduate Education, Department of Urology and Surgical Andrology, Moscow, Russia
   
Poster Board 28
IBANDRONATE AT BONES PAIN OF THE PATIENTS WITH EXTENSIVE PROSTATE CANCER
A.R. Izairi, A.D. Deari, S.B. Bozinovska, Z.P. Perovski, P.S. Izairi                     
Department of Urology, Clinical Hospital, Tetovo, FYR of Macedonia
   
Poster Board 29
ELEVATED AND/OR RISING PSA IN PRESENCE OF NEGATIVE BIOPSY: CANCER, INFLAMATION OR WATCHFUL WAITING, DILEMMA OF DECISION MAKING
M. Wishahi
, A. Nehena, A.M. Elkholy, H.M. Elganzory, H. Nour, E.M. Riad                  
Urology Department, Theodor Bilharz Research Institute, Cairo, Egypt
    
Poster Board 30
KOREA PROSTATE BANK
I.G. Kim
, J.H. Han, J.Y. Lee, S. Piao, J.Y. Lee                    
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul Korea
    
Poster Board 31
THE CORRELATION BETWEEN HOMOGENEITY OF GLEASON SCORE AT PROSTATE BIOPSY AND PATHOLOGICAL FINDINGS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PROSTATE CANCER
W.T. Kim1, S.J. Yun1, S.W. Jo2, Y.W. Kim1, Y.J. Kim1, S.C. Lee1, W.J. Kim               
1Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea
2Department of Urology, Cheongju Saint Mary's Hospital, Cheongju, Korea
   
Poster Board 32
IMPACT OF DIGITAL RECTAL EXAMINATION (DRE) ON TOTAL SERUM LEVELS OF PROSTATE SPECIFIC ANTIGEN (TPSA)
C. Komninos
, M. Karavitakis, S. Koutsikos, V. Simaioforidis,
V. Politis, G. Lefakis, S. Koritsiadis               
Urology Department of General Hospital Nikaia “Saint Panteleimon”, Piraeus, Greece

Poster Board 33
DIFFERENCES IN THE PROGNOSTIC VALUE OF THE PROSTATE VOLUME, TUMOR VOLUME, AND TUMOR PERCENTAGE BETWEEN PATHOLOGIC T2 AND T3 RADICAL PROSTATECTOMY SPECIMENS
K.H. Lee1
, I.C. Cho1, W.A. Kwon1, J.E. Kim1, J.Y. Jeong1,
H.K. Seo1, J.C. Chung1, W.S. Park1, E.K. Hong2        
1Center for Prostate Cancer, National Cancer Center; 2Department of Pathology, National Cancer Center, Koyang-si, Korea

Poster Board 34
COST EXPENDITURES FOR ACTIVE SURVEILLANCE VERSUS ACTIVE TREATMENTS FOR LOCALIZED PROSTATE CANCER
K.R. Loughlin
, R.S. Lavelle, S.B. Williams                            
Harvard Medical School, Boston, USA

Poster Board 35
OBESITY AND THE RISK OF PROSTATE CANCER AFTER AN INITIAL NEGATIVE PROSTATE NEEDLE BIOPSY
K.R. Loughlin, L. Ramos, R. Kacker, L. Trevino                        
Harvard Medical School, Boston, USA

Poster Board 36
ONCOLOGIC AND FUNCTIONAL RESULTS IN SEMINAL VESISCLES SPARING RADICAL PROSTATECTOMY: OUR EXPERIENCE
M. Mari
, S. Guercio, A. Ambu, F. Mangione, F. Vacca, S. Canessa, M. Bellina               
Rivoli Hospital, Rivoli, Italy

Poster Board 37
SIZE – DOES IT MATTER (IN ROBOT ASSISTED PROSTATECTOMY)?
S. Mukhtar
, H. Alnajjar, R. Issa, M. Perry, C. Anderson                    
St George's NHS Trust, London, UK

Poster Board 38
COST-MINIMISATION ANALYSIS OF LHRH AGONISTS FOR PROSTATE CANCER TREATMENT IN RUSSIA
I. Odeyemi
, E. Baskin-Bey, V. Munro
Astellas Pharma Europe, Department of Urology, Staines, UK

Poster Board 39
CONTINUING OR DISCONTINUING LOW DOSE ASPIRIN PRIOR TO PROSTATE BIOPSY?
D.Z. Perovic1
, D.M. Durovic1, P.V. Kavaric1, D.Z. Ivanovic2                        
1Department of Urology, Clinical Center of Montenegro, Podgorica, Montenegro
2Codra Hospital, Podgorica, Montenegro

Poster Board 40
BLADDER NECK SPARING RADICAL RETROPUBIC PROSTATECTOMY: RESULTS ON CONTINENCE AND POSITIVE SURGICAL MARGINS
G. Perugia1, S. Teodonio1, A. Chinazzi2, D. Di Viccaro1, F. Antonini1, G. Borgoni1,
M. Liberti1              
1Department of Urology & 2Department of Biochemical Sciences, "Sapienza" University, Rome, Italy

Poster Board 41
HUMAN SERUM ADIPONECTIN (ADIPOQ) HAS SIMILAR PRESENCE AMONG DIFFERENT PROSTATE PATHOLOGIES
F.M. Pina1,2, G. Figueiredo3, N. Lunet4,5, F. Botelho2,4,
I. Lopes1,2, T. Lopes1,2, F. Cruz1,2, H. Barros4,5            
1Department of Urology, Faculdade de Medicina, Universidade do Porto; 2Department of Urology, 3Department of Immunology, Hospital de São João do Porto; 4Department of Hygiene e Epidemiology, Faculdade de Medicina, U. do Porto & 5Public Health Institute, Universidade do Porto (ISPUP), Portugal

Poster Board 42
ACTIVE SURVEILLANCE FOR PROSTATE CANCER: A NOMOGRAM PREDICTING THE RISK OF UPGRADIG/UPSIZING AT 1 YR RE-BIOPSY
T. Rancati1, R. Valdagni1, M. Colecchia2, R. Salvioni3, S. Villa4, N. Bedini4, D. Biasoni3,
C. Marenghi1, B. Avuzzi1, B. Paolini2,T. Magnani1, S. Catania1
1Scientific Director's Office, Prostate Program, 2Department of Anatomopatholy, 3Department of Urology & 4Department of Radiation Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy

Poster Board 43
RETROURETHRAL TRANSOBTURATOR SLING ADVANCE FOR THE TREATMENT OF MALE SUI AFTER RADICAL PROSTATECTOMY: A SINGLE INSTITUTION EXPERIENCE OF 43 CASES
E. Rijo
, O. Bielsa, J.A. Lorente, G. Nohales, A. Rodriguez, O. Arango                  
Department of Urology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain

Poster Board 44
STAGING RECTOURINARY FISTULAE AFTER RADICAL PROSTATECTOMY
E. Rijo1, J.A. Lorente1, O. Bielsa1, M. Pera2, A. Francés1, O. Arango1                 
&
THE POSTERIOR TRANS-SPHINCTERIC-TRANSRECTAL APPROACH (YORK-MASON TECHNIQUE) FOR REPAIR OF RECTO-URINARY FISTULAS AFTER RADICAL PROSTATECTOMY: A SINGLE INSTITUTION EXPERIENCE

E. Rijo1
, J.A. Lorente1, O. Bielsa1, M. Pera2, A. Francés1, G. Nohales1, O. Arango1               1Department of Urology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain
2Department of Surgery, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain

Poster Board 45
FINAL PATHOLOGY UPGRADE OF PATIENTS WITH LOW RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY
F. Rozet1, F.P. Secin2, R.E. Sanchez-Salas1, V. Flamand1,M. Galiano1, D. Prapotnich1,
A. Mombet1, N. Cathala1, E. Barret1, X. Cathelineau1     
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina

Poster Board 46
INTERMITTENT ANDROGEN DEPRIVATION AS SECONDARY THERAPY FOR BIOCHEMICAL RECURRENCE OF LOCALIZED PROSTATE CANCER
R.E. Sanchez-Salas1
, D. Prapotnich1, F.P. Secin2, R. Favaretto1, F. Rozet1, M. Galiano1,
E. Barret1, N. Cathala1, A. Mombet1 X. Cathelineau1     
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina
 
Poster Board 47
LONG TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH HIGH INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER
R.E. Sanchez-Salas1, D. Prapotnich1, F.P. Secin2, R. Favaretto1, E. Barret1, M. Galiano1, F. Rozet1, X. Cathelineau1            
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina
 
Poster Board 48
PIONEERING INSTITUTION MID AND LONG TERM OUTCOMES OF LAPAROSCOPIC RADICAL PROSTATECTOMY
R.E. Sanchez-Salas1
, F.P. Secin2, D. Prapotnich1, F. Bianco Jr.3, E. Barret1, F. Rozet1,
M. Galiano1, N. Cathala1, A. Mombet1, X. Cathelineau1     
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina
3Columbia University at Miami Florida, USA

Poster Board 49
ROBOTIC PROSTATECTOMY ONCOLOGIC OUTCOMES ACCORDING TO RISK GROUP CLASSIFICATION
R.E. Sanchez-Salas1, F.P. Secin2, D. Prapotnich1, F. Rozet1, M. Galiano1, N. Cathala1,
A. Mombet1, E. Barret1, X. Cathelineau1        
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina

Poster Board 50
ROBOTIC PROSTATECTOMY POSITIVE MARGINS LEARNING CURVE
R.E Sanchez-Salas1, F.P. Secin2, D. Prapotnich1, F. Rozet1, M. Galiano1, V. Flamand1,
A. Mombet1, N. Cathala1, E. Barret1, X. Cathelineau1     
1Institut Montsouris, Paris, France
2CEMIC, Buenos Aires, Argentina

Poster Board 51
INTRAPROSTATIC LYMPHATIC VESSELS: NEGLECTED DISTRIBUTION, ORGANISATION AND ONCOLOGICAL CONSEQUENCES
P.E. Stoemmer1, P. Torres-Galea1, C. Neusiedl2                           
1Forschungslabor Pathologie, Augsburg, Germany
2Semmelweiss University, Budapest, Hungary

Poster Board 52
HIFU - OUR EXPERIENCE IN INDIA
S.Z. Tabrez, M. Keshavmurthy                                
Fortis Hospital, Bengaluru, India

Poster Board 53
FOCAL SALVAGE FOR PROSTATE CANCER RECURRENCES
M. van Vulpen, M. Peters, U.A. van der Heide                           
UMC Utrecht, Utrecht, The Netherlands

Poster Board 54
BONE-MARKER LEVELS AND POTENTIAL CORRELATION WITH OUTCOMES IN PATIENTS WITH PROSTATE CANCER AND BONE METASTASIS: PRELIMINARY RESULTS OF TUGAMO TRIAL
F. Vazquez1, A. Gomez Caamaoo2, M.J. Ribal3, L. Leon2, E. Esteban4, C. Gonzalez Enguita5, E. Solsona6, C. Olivier7, J.L. lvarez-Ossorio8, J.A. Contreras8, J. Morote9  
1Hospital Universitario Virgen de las Nieves, Granada, Spain; 2Complejo Hospitalario Universitario de Santiago, A Coruסa, Spain; 3Hospital Clinic i Provincial de Barcelona, Spain; 4Hospital Central de Asturias, Oviedo, Spain; 5Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz, Madrid, Spain; 6Instituto Valenciano de Oncologia, Valencia, Spain; 7Hospital Clinico San Carlos, Madrid, Spain; 8Hospital Puerta del Mar, Cadiz, Spain & 9Hospital Universitario de la Vall d’Hebron, Barcelona, Spain

Poster Board 55
MODELING THE PUBLIC HEALTH IMPACT OF RISK REDUCTION OF PROSTATE CANCER (PCA) WITH DUTASTERIDE CHEMOPREVENTION (CP) IN FRANCE
A. Villers1
, B. Dervaux2, L. Molinier3, F.-E. Cotte4, P. Grosclaude5, A. Lafuma6, C. Le Fur4, A. Slama4, X. Colin6        
1Urology, Universiti Lille Nord de France, Lille, France
2Universiti Droit et Santi Lille 2, Lille, France
3Departement d’Information Medicale, CHU Hotel-Dieu Saint-Jacques, Toulouse, France
4Health Economics & Outcomes Research, GlaxoSmithKline France, Marly le Roi, France
5Tarn Cancer Registry, Albi, France
6Cemka Eval, Bourg la Reine, France
 
Poster Board 56
SALVAGE AND PRIMARY 17G CRYOABLATION FOR PROSTATE CANCER - A PAN EUROPEAN EXPERIENCE
U.K.F. Witzsch1
, D. Greene2, M. Borre3, T. Bjerklund Johansen3                        
1Klinik fur Urologie und Kinderurologie, Krankenhaus Nordwest, Frankfurt, Germany
2Department of Urology, Sunderland Royal University Hospital, Sunderland, UK
3Urology Department, Aarhus University Hospital, Aarhus, Denmark

Poster Board 57
SALVAGE CRYOABLATION OF PROSTATE CANCER USING 17 G CRYONEEDLES TECHNOLOGY: AN LOCAL OPTION AFTER RADICAL PROSTATECTOMY FAILURE!
U.K.F. Witzsch
, S. Hieronymi, G. Voss, E.W. Becht                        
Klinik fur Urologie und Kinderurologie, Krankenhaus Nordwest, Frankfurt, Germany

Poster Board 58
PALM GAMMA-T3 AS AN EFFECTIVE AGENT IN TARGETING PROSTATE CANCER STEM CELL-LIKE POPULATION
D.Y.L. Yap1
, Y.C. Wong1, M.T. Ling2, W.N. Yap1                        
1Davos Life Science, Singapore
2Australian Prostate Cancer Research Centre, Australia

Poster Board 59
TESTOSTERONE TREATMENT IN ELDERLY HYPOGONADAL PATIENTS DOES NOT INCREASE PROSTATE CANCER RISK: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY. 6 YEARS FOLLOW UP ANALYSIS TO AGE-MATCHED CONTROLS
A. A. Yassin1
,2,3, A. D.-J. Yassin4, A. Haider5, F.A. Saad6,7                        
1Institute of Urology & Andrology, Segeberger Kliniken, Norderstedt-Hamburg/Germany
2Dresden International University, Program of Preventive Medicine, Dresden/Germany
Gulf Medical University School of Medicine, Ajman/UAE
4Asklepios Klinik Barmbek, Dept. of Urology, Hamburg/Germany
5Private Urologic Practice, Bremerhaven/Germany
6Bayer Schering Pharma AG, Berlin/Germany
7Gulf Medical University, Research Dept., Ajman/UAE

Poster Board 60
AMORPHOUS NANOSILICA INDUCES MHC CLASS I-RESTRICTED PRESENTATION OF EXOGENOUS ANTIGENS
T. Yoshikawa1,2, H. Nabeshi1,2, N. Itoh1,2, Y. Yoshioka2,3, Y. Tsutsumi1,2,3,4                     1Department of Toxicology and Safety Science, Graduate school of Pharmaceutical Sciences, Osaka University
2Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation (NiBio)
3The Center for Advanced Medical Engineering and Informatics, Osaka University
4Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Osaka, Japan

Poster Board 61
THE INSULIN RESISTANCE ASSOCIATES WITH THE CLINICOPATHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER
S.J. Yun1, W.T. Kim1, S.W. Jo2, Y.J. Kim1, S.C. Lee1, W.J. Kim1                 
1Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea
2Department of Urology, Cheongju Saint Mary's Hospital, Cheongju, Korea

URETHRA & TESTIS

Poster Board 62
THE IMPACT OF BODY MASS INDEX ON SPERM RECOVERY AND SERUM REPRODUCTIVE HORMONE LEVELS IN NON-OBSTRUCTIVE AZOOSPERMIA
H. Hibi1, T. Ohori1, Y. Yamada2, N. Honda2, Y. Asada3                    
1Department of Urology, Kyoritsu General Hospital
2Department of Urology, Aichi Medical University School of Medicine
3Asada Lady’s Clinic

Poster Board 63
PENILE HYPOSPADIAS WITH CHORDEE REPAIR: A NOVEL ONE-STAGE TECHNIQUE
D.K. Radopoulos, G.P. Dimitriadis, S.S. Ioannidis, P.T. Dimopoulos, K.A. Tzakas                     
1st Department of Urology, Aristotle University of Thessaloniki, Greece


MISCELLANEOUS
Poster Board 64
PROSTATE I 125 BRACHYTHERAPY: CRITICAL EVALUATION OF MID TERM ONCOLOGIC AND FUNCTIONAL RESULTS AFTER 250 CASES
P. Cortese, E. Gastaldi, L. Chiono, F. Gallo, C. Giberti
Dipartimento di Chirurgia, S.C. Urologia, Ospedale San Paolo, Savona, Italy

Poster Board 65
PHYSIOLOGICAL PATTERN OF SECRETION OF URINARY NEUROTROPHINS IN HEALTHY MALE AND FEMALE VOLUNTEERS
A. Lopes Tiago1,2,4, R. Pinto1,2,4, S.C. Barros3,4, P. Diniz1,2,4, C. Silva1,2,4, C.D. Cruz3,4, F. Cruz1,2,4              
1Department of Urology, Hospital de Sao Joao, Porto; 2Faculty of Medicine, 3Institute of Histology and Embryology, Faculty of Medicine & 4Instituto de Biologia e Molecular e Celular – IBMC, University of Porto, Porto, Portugal

Poster Board 66
MEDICAL NOTES WEIGHT GAIN DURING UROLOGY HOSPITAL ADMISSIONS
S. Katmawi-Sabbagh, L. Teng Hong, K. Murva, M. Al-Sudani, R.C. England                    
Kettering General Hospital, Kettering, UK  

Poster Board 67
DIAGNOSIS OF URETHRAL DIVERTICULA IN WOMEN: VALUE OF PERINEAL ULTRASOUND IMAGING
J. Neymeyer                                  
Department of Urology, University – Charitè, Berlin, Germany

Poster Board 68
COMPARISON OF THE GE VSCAN PORTABLE ULTRASOUND DEVICE WITH A CONVENTIONAL ULTRASOUND DEVICE IN EXAMINATION OF THE GENITO-UINARY TRACT
J. Neymeyer1; W. Abdul-Wahab Al-Ansari2
1Department of Urology, University Charite – Berlin & 2Department of Urology, Franziskus-Hospital-Berlin, Germany
 
Late Addition
 
Poster Board 69
RESISTANCE OF UROPATHOGENS IN VITRO AND CLINICAL OUTCOMES OF ANTIBACTERIAL THERAPY OF UNCOMPLICATED URINARY TRACT INFECTIONS
V. Rafalskiy1
, 2, V. Khodnevitch1, V. Dovgan1
                           
1Smolensk State Medical Academy & 2Institute of Clinical Pharmacology, Smolensk, Russia

 
 

Home   
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 05/11/2011 Created by     WebStudio.co.il